Pfizer extends HIV/AIDS drug program in Africa, Haiti
BY Advocate.com Editors
January 14 2003 1:00 AM ET
Pharmaceutical companies Pfizer Inc. and the Pfizer Foundation announced Monday an agreement to indefinitely extend their Diflucan Partnership Program in southern Africa and Haiti, according to AIDS Weekly. The program provides free doses of the drug Diflucan, which treats two opportunistic infections associated with HIV/AIDS.
"At Pfizer, we know that the battle against HIV/AIDS must be fought on many fronts," said Pfizer chairman and CEO Hank McKinnell. "Through new and expanded programs, we are helping get medicines to those most in need, showing Pfizer employees how they can help fight the pandemic, and partnering with international organizations to provide care, treatment, and prevention in the countries hardest hit by HIV/AIDS."
The Pfizer Foundation also announced the awarding of $1.8 million to 12 organizations through its new International HIV/AIDS Health Literacy Grants Program. The organizations selected will conduct HIV/AIDS health literacy programs in the countries hardest hit by the pandemic.
Sign Up For Email Updates
- Entertainment News How To Take Down An Anti-Gay 'Victim' 12 min 29 sec ago
- Arts & Entertainment PHOTOS: Perez Hilton Vs. Inflatable Alligator 19 min 6 sec ago
- Entertainment News One Direction: Caught Twerking—and in Calvins 34 min 17 sec ago
- Entertainment News Need to Know: Alabama’s All-Male Cheerleading Squad 45 min 14 sec ago
- Sports National Gay & Lesbian Sports Hall of Fame’s First Class Announced 1 hour 13 min ago
- Arts & Entertainment Did Chris Colfer Get Arrested? 1 hour 19 min ago
- Entertainment News EXCLUSIVE: Madonna's MDNA Concert Clip 2 hours 1 min ago